Brett Abrahams - drug development and neurogenomics

Brett Abrahams, Executive VP of R&D at Magnolia Neurosciences, discusses his work on chemotherapy-induced peripheral neuropathy and other brain disorders.

The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of biotechnology companies, with a focus on genomics.

https://www.bioinformaticscro.com/